Who invested in EpiVax?
EpiVax's investors include National Institutes of Health, Morningside Group, Slater Technology Fund, GBS/CIDP Foundation International and Horatio Investments, and 2 more on record.

United States · Bridge startup
Funding summaryUpdated 26 Oct 2026
$4.9Mraised across 9 rounds since 1998, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs and 1 other
From EpiVax's own website: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
EpiVax's investors include National Institutes of Health, Morningside Group, Slater Technology Fund, GBS/CIDP Foundation International and Horatio Investments, and 2 more on record.
EpiVax has raised $4.9M across 9 rounds since 1998. One round did not disclose an amount, so the total is a floor.
EpiVax's most recent round was a Bridge of $1.2M in Jun 2018.
EpiVax's largest round on record is $1.5M (Grant), in Apr 2012.
EpiVax's first round on record, in Jan 1998, was backed by Slater Technology Fund.
EpiVax's latest named round is a Bridge, in Jun 2018.
EpiVax is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.